Revvity RVTY
NYSE RVTY
$146.80 +1.07 (+0.73%)
As of: Sep 17, 2026 · 3:59 PM EDT

Revvity (RVTY) Total Current Liabilities (2010 - 2026)

Revvity's (RVTY) quarterly Total Current Liabilities came in at $1.3 billion in Q3 2026, up 89.99% on a YoY basis from $671.8 million in Q3 2025, and up 3.04% quarter-over-quarter from $1.2 billion in Q2 2026.

Analysis

Revvity (RVTY) Total Current Liabilities (2010 - 2026) Analysis & Trends

Revvity (RVTY) has reported Total Current Liabilities for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q3 2026.

  • For the quarter ending Q3 2026, Total Current Liabilities rose 89.99% year-over-year to $1.3 billion; the trailing twelve-month figure through Jul 2026 stood at $1.3 billion (up 89.99% YoY), and the FY2025 full-year result was $1.3 billion, up 103.83% from the prior year.
  • Total Current Liabilities grew to $1.3 billion in Q3 2026 per RVTY's latest filing, from $1.2 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.6 billion in Q2 2023 and bottomed at $648.2 million in Q1 2025.
  • Historically, Total Current Liabilities has averaged $1.2 billion across 5 years, with a median of $1.3 billion in 2026.
  • The sharpest annual moves came in 2024 and 2025: Total Current Liabilities sank 54.97% in 2024, then soared 103.83% in 2025.
  • Over 5 years, Total Current Liabilities stood at $1.5 billion in 2022, then dropped by 2.37% to $1.5 billion in 2023, then tumbled by 54.97% to $653.1 million in 2024, then surged by 103.83% to $1.3 billion in 2025, then dropped by 4.12% to $1.3 billion in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $1.3 billion, $1.2 billion, and $1.3 billion for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 15.07 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 8.11 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 2.29 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 1.58 Bn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 1.28 Bn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 163.70 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 961.30 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 132.66 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 118.51 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 1.20 Bn
Historic Data

Historic Data

Download Data
DateValue
Jul 5, 2026 1.28 Bn
Apr 5, 2026 1.24 Bn
Dec 28, 2025 1.33 Bn
Sep 28, 2025 1.22 Bn
Jun 29, 2025 671.81 Mn
Mar 30, 2025 648.19 Mn
Dec 29, 2024 653.10 Mn
Sep 29, 2024 687.94 Mn
Jun 30, 2024 1.39 Bn
Mar 31, 2024 1.37 Bn
Dec 31, 2023 1.45 Bn
Oct 1, 2023 1.45 Bn
Jul 2, 2023 1.37 Bn
Apr 2, 2023 1.56 Bn
Jan 1, 2023 1.54 Bn
Oct 2, 2022 1.49 Bn
Jul 3, 2022 1.04 Bn
Apr 3, 2022 1.26 Bn
Jan 2, 2022 1.21 Bn
Oct 3, 2021 1.15 Bn